Molecules (Oct 2022)

Thiazolidin-2,4-Dione Scaffold: An Insight into Recent Advances as Antimicrobial, Antioxidant, and Hypoglycemic Agents

  • Harsh Kumar,
  • Navidha Aggarwal,
  • Minakshi Gupta Marwaha,
  • Aakash Deep,
  • Hitesh Chopra,
  • Mohammed M. Matin,
  • Arpita Roy,
  • Talha Bin Emran,
  • Yugal Kishore Mohanta,
  • Ramzan Ahmed,
  • Tapan Kumar Mohanta,
  • Muthupandian Saravanan,
  • Rakesh Kumar Marwaha,
  • Ahmed Al-Harrasi

DOI
https://doi.org/10.3390/molecules27196763
Journal volume & issue
Vol. 27, no. 19
p. 6763

Abstract

Read online

Heterocyclic compounds containing nitrogen and sulfur, especially those in the thiazole family, have generated special interest in terms of their synthetic chemistry, which is attributable to their ubiquitous existence in pharmacologically dynamic natural products and also as overwhelmingly powerful agrochemicals and pharmaceuticals. The thiazolidin-2,4-dione (TZD) moiety plays a central role in the biological functioning of several essential molecules. The availability of substitutions at the third and fifth positions of the Thiazolidin-2,4-dione (TZD) scaffold makes it a highly utilized and versatile moiety that exhibits a wide range of biological activities. TZD analogues exhibit their hypoglycemic activity by improving insulin resistance through PPAR-γ receptor activation, their antimicrobial action by inhibiting cytoplasmic Mur ligases, and their antioxidant action by scavenging reactive oxygen species (ROS). In this manuscript, an effort has been made to review the research on TZD derivatives as potential antimicrobial, antioxidant, and antihyperglycemic agents from the period from 2010 to the present date, along with their molecular mechanisms and the information on patents granted to TZD analogues.

Keywords